Authors:
Oka, M
Fukuda, M
Fukuda, M
Kinoshita, A
Kuba, M
Ichiki, M
Rikimaru, T
Soda, H
Takatani, H
Narasaki, F
Nagashima, S
Nakamura, YI
Hayashi, N
Kohno, S
Citation: M. Oka et al., Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer, EUR J CANC, 37(11), 2001, pp. 1359-1365
Authors:
Ichinose, Y
Yosimori, K
Yoneda, S
Kuba, M
Kudoh, S
Niitani, H
Citation: Y. Ichinose et al., UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma - A multiinstitutional Phase II trial, CANCER, 88(2), 2000, pp. 318-323
Authors:
Sakamoto, T
Nishimura, A
Tamaoki, M
Kuba, M
Tanaka, H
Iwahori, S
Matsuoka, M
Citation: T. Sakamoto et al., The conserved KNOX domain mediates specificity of tobacco KNOTTED1-type homeodomain proteins, PL CELL, 11(8), 1999, pp. 1419-1431
Authors:
Asamoto, H
Kawahara, M
Iwami, F
Kuba, M
Furuse, K
Tamura, T
Saijo, N
Shimoyama, M
Citation: H. Asamoto et al., Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer, JPN J CLIN, 28(12), 1998, pp. 745-748